SREBF1 and alcoholic liver diseases: Gentiopicroside, in both acute and chronic alcohol induced mouse hepatosteatosis (the later stage of alcoholic liver disease, ALD) models, mitigated the upregulation of SREBP-1 and downregulation of PPAR-α, among others, by activation of AMPK [37,41].